Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Voyager Therapeutics, Inc.

NASDAQ: VYGR · Life Sciences · 3 alerts · CIK 1640266

Share price
$1.63Close, Nov 16
Market cap
$101M
Shares outstanding
62.23MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Voyager Therapeutics, Inc. filings on SEC EDGAR ↗

8:07 AM ET 8-K
Executive Compensation

Voyager Therapeutics Executive Compensation

Voyager Therapeutics appointed Robin Swartz as President and announced she will succeed Alfred W. Sandrock, Jr. as CEO in Q1 2027. In connection with the promotion, Swartz entered into an amended employment agreement providing for a $625,000 base salary, a 50% target bonus, and equity grants including 318,500 stock options and 68,250 restricted stock units.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.